ERT has established strategic alliances and partner relationships that help drive efficiency throughout the drug development process, from clinical trials to late phase and observational studies. By proactively seeking complementary businesses delivering the same quality of service, we are able to create a network of partners who we can work with to create integrated solutions.



Strengthening our services through strategic partnerships.

Through our partners program, we look beyond what ERT can offer to you and explore additional resources that can deliver better results for the mutual benefit to both our partner and our client. It’s a valuable opportunity to provide multiple efficiencies that neither company could offer alone.

Pharmaceutical companies are challenged now, more than ever, to conduct their clinical research more efficiently in order to reduce costs yet maintain — and improve — their level of productivity. There is an increasing demand for capacity, speed, an expanded geographic footprint, and cost containment in order to grow in the pharmaceutical industry. ERT can help Contract Research Organizations (CROs), clinical pharmacology units and ancillary service providers drive additional value to sponsor organizations. By building collaborative working relationships, both client and partner are able to make vast improvements to the communication, integration and overall ability to elevate the trial experience.

Working together with ERT, our partners benefit from a broad range of integrated services, global presence, financial stability, and best-in-class quality. The greater the transparency as part of a bigger team, the more expanded service levels we are able to deliver. Processes become more aligned and long-term value is created. For our clients, this means better science at a lower cost — adding value and innovation to your clinical trials.



At the core of our business are strategic alliances that are designed to add more value to your clinical trial. It is the goal of ERT to align your needs with the expertise of companies who can relieve the industry pressures while increasing your efficiency. 

Click to see a full list of our strategic alliances and how they can put their expertise to work for you.

Covance: The ERT/Covance partnership establishes a platform for enhanced delivery of our cardiac services to our clients. At ERT, we have the expertise and capabilities to provide centralized ECG services powered by our robust and market-leading EXPERT Technology Platform, and we are proud to offer these same services to Covance's clients. The breadth and depth of Covance's clinical services - coupled with ERT's commitment to innovative technology for the collection, interpretation and distribution of cardiac and clinical data - provides our clients with the comprehensive solutions vital to ensuring drug safety.

e-Trial Co., Ltd.: e-Trial Co., Ltd. is a 100% subsidiary company specialized in IT CRO of EPS Corporation, the leading CRO in Japan and Asia. e-Trial supports development and operation of clinical trial systems such as EDC, IWRS, and ePRO with superior quality.

Healthcare Technology Systems, Inc. (HTS): HTS is the pioneer in developing clinical interactive voice response (IVR) systems to collect data directly from patients for pharmaceutical companies, healthcare organizations, and researchers. HTS also offers personalized IVR self-help programs for patients that work. With academic origins at the University of Wisconsin and more than three decades of published research, HTS and its principals are world renowned for their research expertise, educational accomplishments, and innovative computer-administered rating scales.

Site Support Institute Co., Ltd. (SSI): Site Support Institute Co., Ltd. (SSI) is one of the leading nationwide SMOs (Site Management Organization) in Japan. SSI manages various duties derived from clinical trial implementation and assists medical institutions with performing various tasks throughout the clinical trial process.

Statistical Resources, Inc.: Statistical Resources, Inc. is a strategic statistical, statistical programming and data-management resources consulting firm with special emphases and experience in the pharmaceutical, biotech and medical devices industries. Statistical Resources specializes in services specific to these industries for clinical studies and submission to the U.S. Food and Drug Administration (FDA) and other regulatory agencies worldwide.



ERT creates partnerships based on trust so you can be confident that your best interest is always at the forefront of the relationship. With a dependable partner supporting the needs of your trial, you are able to shift your focus from day-to-day operational tasks to higher value strategic aspects of your business.

Click to see a full list of our partner relationships to learn about the value they can add to your clinical trial.

ACR Image Metrix: An imaging contract research organization (CRO) located in the American College of Radiology Clinical Research Center in Philadelphia, applies imaging techniques to improve the efficiency of drug and medical device development programs. The world-class team of radiologists and imaging scientists at ACR Image Metrix work with pharmaceutical, biotech and medical device companies to integrate the appropriate imaging technologies, modalities and clinical design techniques into their imaging studies. ACR Image Metrix has years of experience utilizing state-of-the-art technologies to provide a complete line of imaging services from site qualification and training, study initiation, image management, reader studies and much more.

Applied Clinical Intelligence: Applied Clinical Intelligence provides decision makers with the trusted information they need to clearly communicate the value and safety of medical treatments, drugs and devices. Applied Clinical Intelligence enables pharmaceutical, biotechnology, medical device and health care customers to realize process efficiencies and resulting savings in cost and time. 

ChanTest: ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately, help make better, safer drugs. The preeminent ion channel services company, ChanTest serves its drug discovery and development customers with GLP (Good Laboratory Practice) safety assays and automated-profiling assays, using its library of ion channel-expressing cell lines.

Comprehensive Clinical Development: Comprehensive Clinical is a strategic clinical research partner providing a full range of clinical development services in many therapeutic areas. Recognized for consistently delivering quality and success on time and within budget, Comprehensive Clinical Development holds a solid track record of collecting early efficacy data across various patient populations.  Comprehensive’s three clinical pharmacology units and five patient-focused research centers can support Phase 0-4 studies, including very complex early phase studies in healthy volunteers or special populations, notably Phase 0 and 1 studies in oncology populations.

CROss Alliance: The ERT–CROss Partnership allows one of the main experts in the evaluation of Cardiovascular Safety to operate in a unique pharma-country, Switzerland, where CROss Alliance has operated since 1997 and ensures a deep knowledge of the local regulations and a proven experience in the performance of Phase I studies in a selected healthy population. The formal partnership follows several years of reciprocally fruitful cooperation which, together with the highly standardized quality of the two partners, is a guarantee for our Customers’ investments.

ICON Clinical Research, Inc.: ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.

PAREXEL: PAREXEL is a leading global biopharmaceutical services organization that helps clients expedite time-to-market through development and launch services. These include a broad range of clinical-development capabilities, integrated advanced technologies, regulatory-affairs consulting and commercialization services.

SeaView Research, Inc. : SeaView Research provides Phase I and early Phase II clinical pharmacology testing to the pharmaceutical and biotech industries. SeaView prides itself in performing the most demanding and complex protocols while maintaining uncompromising standards of quality, integrity, and timeliness. We offer exceptional client-focused service led by a full-time staff of more than 160 employees including three board certified physicians, physicians assistant, a registered dietitian, 2 pharmacists, and ACRP certified RN study coordinators. Our medical staff is highly experienced in the intricacies of thorough QT / QTc studies, having performed over 20 such studies in the past 5 years.

South Texas Accelerated Research Therapeutics: (START) is located in San Antonio. Its mission is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research. In 2008, START expanded globally with the launch of START Madrid which aims to keep the development of anticancer agents operating 24 hours a day. Because of the work of scientists like those at START, and the continuing advances in technology, real progress is being made against cancer and we are able to improve the tools to understand, detect, and diagnose cancer. Today, people with cancer are living longer than ever before with a better quality of life. 

Swiftwater Group:  is a specialty consulting firm that focuses on assisting their clients in managing the Pharmaceutical Development Process. Founded in 1998 by industry veterans, Swiftwater Group has helped its clients navigate the rigors of the approvals processes in the US, Europe, and Japan. Offering expertise from early discovery and non-clinical studies to Phase I through IV clinical trials, Swiftwater Group works closely with clients to design optimal development strategies (minimizing risk and financial investment where possible). Swiftwater Group’s offerings include creating non-clinical and clinical studies; managing CROs to ensure protocols and programs are adhered to (including full QA/QC capabilities); and delivering clear and concise regulatory documentation to governing agencies (including IND, NDA, CTD, DMF).

Swiss Pharma Contract, Ltd.: As an International CRO, Swiss Pharma Contract, Ltd. offers a variety of services focused on clinical pharmacology and clinical research, ranging from first testing of a new drug in man to post-marketing clinical studies.

Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.